Basic Information
| LncRNA/CircRNA Name | LINC01787 |
| Synonyms | NA |
| Region | GRCh38_1:96254069-96374125 |
| Ensemble | ENSG00000231987 |
| Refseq | NR_110693 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qRT-PCR, Western blot, RIP |
| Sample | breast cancer tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LINC01787 is up-regulated in breast cancer tissues and is associated with advanced stages and poor survival. our findings identified a novel up-regulated and oncogenic lncRNA LINC01787 in breast cancer, which binds pre-miR-125b and represses mature miR-125b generation. |
| Pubmed ID | 31750242 |
| Year | 2019 |
| Title | Long Non-coding RNA LINC01787 Drives Breast Cancer Progression via Disrupting miR-125b Generation |
External Links
| Links for LINC01787 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |